Collectively, all data from our study demonstrate that miR-181c over-expression alleviated lung injury in COPD, as evident from the resulting amelioration of lung injury, reduction of the inflammatory response, neutrophil infiltration, and ROS generation, and down-regulation of CCN1 expression. The gene discussed is CCN1; the disease is chronic obstructive pulmonary disease.